[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
July 23/30, 2014

Integrating HIV Prevention Into Practice

Author Affiliations
  • 1Kirby Institute, University of New South Wales, Sydney, Australia
  • 2HIV, Immunology, and Infectious Diseases Clinical Services Unit, St Vincent’s Hospital, Sydney, Australia
JAMA. 2014;312(4):349-350. doi:10.1001/jama.2014.8606

At the beginning of the human immunodeficiency virus (HIV) epidemic 30 years ago, the main methods for prevention were clean needles and condoms. Even though these available methods would work, their success was completely dependent on human behavior. However, over the past decade, biomedical prevention of HIV has come of age, in the wake of the extraordinary success of antiretroviral therapy (ART) for treatment of the HIV-infected person. In quick succession, effective approaches for prevention were developed and implemented, including prevention of mother-to-child HIV transmission through birth and breastfeeding, medical male circumcision, preexposure prophylaxis (PrEP), vaginal microbicides, and prevention of transmission to uninfected partners of an HIV-infected person with effective ART.

First Page Preview View Large
First page PDF preview
First page PDF preview
×